FDA Panel Votes In Favor Of Pfizer Covid-19 Vaccine For Children Aged 5 – 11

In a 17-0 vote, the US Food and Drug Administration (FDA) has recommended that the agency authorize the emergency use of Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11.

One member abstained from the vote.